Zoe Prentice

Title: Zoe Prentice: Innovator in FGFR Inhibitors

Introduction

Zoe Prentice is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. Her work focuses on innovative methods of making and using these compounds, which have important implications for medical treatments.

Latest Patents

Zoe Prentice holds a patent for FGFR inhibitors and methods of making and using the same. This patent is directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide, along with its salts, cocrystals, and variants. This innovative work showcases her expertise in the field and her commitment to advancing pharmaceutical science.

Career Highlights

Throughout her career, Zoe has demonstrated a strong dedication to research and development. She is currently associated with Relay Therapeutics, Inc., where she continues to push the boundaries of innovation in drug development. Her work has the potential to impact various therapeutic areas, making her a key figure in her field.

Collaborations

Zoe Prentice collaborates with talented professionals, including André Lescarbeau and Jethro Beamish-Cook. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Zoe Prentice is a pioneering inventor whose work in FGFR inhibitors exemplifies her commitment to advancing medical science. Her contributions are vital to the ongoing development of effective treatments, and her innovative spirit continues to inspire others in the field.